JANIE VILLARIN: Open Payments
NPI 1205956471 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 10 payments from 8 companies in 2025. Trend: 2023 $230 · 2024 $377 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $89 |
| Exeltis, USA Inc. | 1 | $24 |
| Organon LLC | 1 | $22 |
| OptumHealth Care Solutions, LLC | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| MILLICENT US INC | 1 | $18 |
| CooperSurgical, Inc. | 1 | $17 |
Products named: Veozah, SLYND, NEXPLANON, VIVIFY HEALTH CARE TEAM PORTAL 001, QULIPTA, FEMLYV, Paragard T 380A.
Industry payments across VA — which companies pay providers there.
